Wolfgang Miesbach: From CD20 to CD38 – A New Dimension in ITTP Therapy
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn about a recent article by Paul Coppo, published in JTH, adding։
“From CD20 to CD38: a new dimension in iTTP therapy.
Preemptive rituximab guided by ADAMTS13 has transformed iTTP follow-up, but a subset of patients still relapse or remain refractory and need alternative strategies.
In a recent RPTH commentary, Paul Coppo highlights daratumumab in 5 heavily pretreated iTTP patients (8 episodes), with an 87.5% overall response rate, rapid ADAMTS13 recovery in about 2–4 weeks, and a median ADAMTS13 relapse-free survival of 32 months, without reported infectious complications.
By targeting CD38 on long-lived plasma cells, daratumumab depletes persistent anti–ADAMTS13–producing cells that are not eliminated by CD20-directed therapies, offering a mechanistically distinct salvage approach in multiresistant iTTP.”
Title: Daratumumab in relapse-refractory immune-mediated thrombotic thrombocytopenic purpura: additional evidence for its efficacy
Author: Paul Coppo
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 15, 2026, 19:41Looking Beyond Platelet Counts to Quality of Life in ITP – American Society of Hematology
-
Oct 15, 2026, 19:32Markus Gregorio Barbosa: Hepatic VPS35 and Cholesterol Homeostasis
-
Oct 15, 2026, 19:18Emerging Novel Therapies for Hereditary Hemorrhagic Telangiectasia – The Lancet Haematology
-
Oct 15, 2026, 19:04Umberto Pensato: EVT Treatment Effects Across Perfusion Profiles in MeVO Stroke
-
Oct 15, 2026, 18:26Chanakya Nayudu: Presenting My Research at ISTH Congress 2026 in Paris
-
Oct 15, 2026, 18:09Maha Othman: Students Lead World Thrombosis Day 2026 Awareness Events
-
Oct 15, 2026, 17:52Jill de Mol։ Rapamycin Modulates Immune Responses in Aged Atherosclerosis
-
Oct 15, 2026, 17:41Victor Aboyans։ Think About Lipids in VTE
-
Oct 15, 2026, 17:08Babu Mia։ Targeting PPM1D to Eliminate Malignant Stem Cells in Myeloproliferative Neoplasms